This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Asia
See you next year! October 2025
Japan

Delivered as a Hybrid Event

Menu

Makoto Nakayama
Director, Antibody & Biologics Group at Kyowa Kirin
Speaker

Profile

Makoto Nakayama has over 15 years antibody technology and product development experiences. He has been engaged in the study of establishing and applying the REGULGENTTM bispecific antibody technology. He currently works as Director of Antibody & Biologics Group in Research Core Function Laboratories at Kyowa Kirin Co., Ltd., leading antibody and biologics discovery and laboratory automation.

Agenda Sessions

  • Novel Bispecific Antibody Format with Reliable Productivity and Developability and Its Product Application

    , 15:30
    View Session

At this event

Prev
Next
Sai Reddy, PhD
Associate Professor of Systems and Synthetic Immunology
ETH Zurich

See Makoto at Antibody Engineering & Therapeutics Asia